ADVANTAGE INVESTMENT MANAGEMENT, LLC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 143 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.

Quarter-by-quarter ownership
ADVANTAGE INVESTMENT MANAGEMENT, LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$0
-100.0%
1,7250.0%0.00%
-100.0%
Q3 2018$1,0000.0%1,7250.0%0.00%0.0%
Q2 2018$1,000
-75.0%
1,7250.0%0.00%
-50.0%
Q1 2018$4,000
-20.0%
1,7250.0%0.00%0.0%
Q4 2017$5,000
+400.0%
1,725
+245.0%
0.00%
Q3 2017$1,0000.0%5000.0%0.00%
Q2 2017$1,000
-50.0%
5000.0%0.00%
-100.0%
Q1 2017$2,0000.0%5000.0%0.00%0.0%
Q4 2016$2,000
-93.3%
500
-93.3%
0.00%
-90.9%
Q3 2016$30,0000.0%7,420
+9.8%
0.01%
-21.4%
Q2 2016$30,000
+30.4%
6,760
+12.5%
0.01%
+40.0%
Q1 2016$23,000
-74.4%
6,008
+4.6%
0.01%
-78.7%
Q4 2015$90,000
+55.2%
5,744
+4.9%
0.05%
+42.4%
Q3 2015$58,000
-58.0%
5,477
+0.1%
0.03%
-50.7%
Q2 2015$138,000
-13.2%
5,472
-3.9%
0.07%
-25.6%
Q1 2015$159,000
+76.7%
5,696
+15.4%
0.09%
+34.3%
Q4 2014$90,0004,9380.07%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2016
NameSharesValueWeighting ↓
KLP Enterprises, LLC 6,865,006$24,302,000100.00%
TSP Capital Management Group, LLC 886,398$3,138,0001.60%
Marcus Capital, LLC 109,950$389,0000.42%
RTW INVESTMENTS, LP 239,662$848,0000.32%
COLUMBIA WANGER ASSET MANAGEMENT LLC 6,195,855$21,933,0000.31%
Benchmark Capital Advisors 66,800$236,0000.20%
Bellevue Group AG 160,000$566,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 632,944$2,241,0000.09%
PDT Partners, LLC 369,300$1,307,0000.09%
Vident Investment Advisory, LLC 196,715$696,0000.08%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders